Inotersen Subcutaneous and Insulin aspart protamine and insulin aspart Subcutaneous
Determining the interaction of Inotersen Subcutaneous and Insulin aspart protamine and insulin aspart Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Inotersen Subcutaneous-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Inotersen Subcutaneous-Insulin Aspart Protamine Injection
- Inotersen Subcutaneous-Insulin aspart, recombinant Subcutaneous
- Inotersen Subcutaneous-Insulin degludec
- Inotersen Subcutaneous-Insulin Degludec (U-100) Prefilled Pens
- Insulin aspart protamine and insulin aspart Subcutaneous-Inotuzumab ozogamicin
- Insulin aspart protamine and insulin aspart Subcutaneous-Inotuzumab ozogamicin Intravenous
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova 4/1 topical
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova 8/2 topical
- Insulin aspart protamine and insulin aspart Subcutaneous-Inova ACT